Global (AMER, APAC, BRICS and EMEA) Hirudin Market Research Report 2019-2025 (Includes Business Impact of COVID-19)

  • TBI372609
  • November 11, 2019
  • Global
  • 134 pages
  • TSCIR
                                          

Abstract, Snapshot, Market Analysis & Market Definition: Hirudin Market

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results. Hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results. In 2019, the market size of Hirudin is 3532.8 million US$ and it will reach 4176.5 million US$ in 2025, growing at a CAGR of 2.4% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hirudin. This report studies the global market size of Hirudin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Hirudin production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

Market Segmentation, Outlook & Regional Insights: Hirudin Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025: Natural Hirudin Recombinant Hirudin Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025: Thrombosis Disease Tumor Disease Others

Key Players, Recent Developments & Sector Viewpoints: Hirudin Market

The Medicines Company Keyken Minapharm Abbott SALUBRIS Pfizer, Inc Teva Pharmaceutical Industries Ltd DUOPUTAI Pentapharm

Key Insights Covered: Exhaustive Hirudin Market

1. Market size (sales, revenue and growth rate) of Hirudin industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Hirudin industry. 3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Hirudin industry. 4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Hirudin industry.

Research Methodology: Hirudin Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type

1.3.1 Global Hirudin Market Size Growth Rate by Type (2019-2025)

1.3.2 Natural Hirudin

1.3.3 Recombinant Hirudin
1.4  

1.4.1 Global Hirudin Market Share by Application (2019-2025)

1.4.2 Thrombosis Disease

1.4.3 Tumor Disease

1.4.4 Others
1.5 Study Objectives
1.6 Years Considered2 Global Growth Trends
2.1 Production and Capacity Analysis

2.1.1 Global Hirudin Production Value 2014-2025

2.1.2 Global Hirudin Production 2014-2025


|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form